Tag Archives: fda-letter
Johnson & Johnson kept selling Animas insulin pumps after learning of malfunctions
Animas, a Johnson & Johnson company, knew of malfunctions in its insulin pumps, but continued selling those models of insulin pumps anyway, according to an FDA warning letter sent to the company Dec. 27 and released to the public Jan. 10. … Continue reading
Posted in insulin pumps
Tagged animas, fda-letter, fda-warnings, jnj
Avandia maker hid dangers from public for years, says Senate report
“GSK had a duty to sufficiently warn patients and the FDA of its concerns in a timely manner. Instead, GSK executives intimidated independent physicians, focused on strategies to minimize findings that Avandia may increase cardiovascular risk, and sought ways to downplay findings that the rival drug ACTOS (pioglitazone) might reduce cardiovascular risk.” — Baucus/Grassley letter to FDA Continue reading
Posted in Avandia, Defective Drugs, heart attacks
Tagged Avandia, baucus-grassley, fda-letter, GSK, senate-report